ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,209Medicare Part D Prescriptions Filled, Including Refills

Rank: 539 out of 2170

$369K Total Retail Price of All Prescriptions

Rank: 763 out of 2170

389 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 389 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,437 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 370 325 1 1
LISINOPRIL 370 338 1 3
AMLODIPINE BESYLATE 344 333 3 4
LEVOTHYROXINE SODIUM 317 306 4 5
METFORMIN HCL 260 232 5 8
OMEPRAZOLE 233 216 6 2
METOPROLOL SUCCINATE 211 199 7 13
HYDROCHLOROTHIAZIDE 180 170 8 9
GLIMEPIRIDE 169 154 9 31
HYDROCODONE-ACETAMINOPHEN 156 141 S3 10 7
TRAMADOL HCL 145 134 11 18
FUROSEMIDE 140 140 12 6
GABAPENTIN 131 115 13 14
RANITIDINE HCL 124 104 14 40
PRAVASTATIN SODIUM 117 113 15 11
ATENOLOL 113 105 16 23
FENOFIBRATE 112 98 17 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 105 17 20
LOSARTAN POTASSIUM 111 95 19 21
SERTRALINE HCL 109 90 20 25
LOSARTAN-HYDROCHLOROTHIAZIDE 109 105 20 42
WARFARIN SODIUM 108 107 22 15
ZOLPIDEM TARTRATE 106 100 23 17
CRESTOR 102 102 24 24
CITALOPRAM HBR 101 99 25 19
FLUTICASONE PROPIONATE 85 76 26 30
METOPROLOL TARTRATE 83 66 27 10
FLUOXETINE HCL 81 79 28 59
TAMSULOSIN HCL 70 64 29 33
CYMBALTA 69 32 30 44
ATORVASTATIN CALCIUM 68 62 31 12
TRAZODONE HCL 68 64 31 38
BENAZEPRIL HCL 67 56 33 55
METFORMIN HCL ER 66 54 34 35
CARBIDOPA-LEVODOPA 65 63 35 110
LANTUS 61 61 36 51
TRIAMTERENE-HCTZ 60 60 37 66
NEXIUM 58 42 38 22
NAMENDA 58 58 38 48
SYNTHROID 57 45 40 27
POTASSIUM CHLORIDE 55 53 41 16
ALLOPURINOL 55 46 41 29
MIRTAZAPINE 52 52 43 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.